NARI
Inari Medical, Inc.
Set alert
52-week range unavailable
- YTD
- +56.65%
- 1 year
- +41.87%
- Open
- 79.96
- Prev close
- 79.97
- Mkt cap
- 4.68B
- Vol
- 2.36M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 79.96
- High
- 79.97
- Forward P/E
- 571.21
- Beta
- 1.03
- Short ratio
- 0.54
- Inst. own
- 95.56%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 28, 2024
- 50-d avg
- 70.53
- 200-d avg
- 53.51
- 1y target
- 78.03
Key statistics
- Market cap
- 4.68B
- Enterprise value
- 4.60B
- Trailing P/E
- 0.00
- Forward P/E
- 571.21
- PEG ratio
- 0.00
- Price / sales
- 8.15
- Price / book
- 10.75
- EPS (TTM)
- -1.35
- Beta
- 1.03
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -13.68%
- Revenue (TTM)
- 574.50M
- Revenue growth
- 21.40%
- Free cash flow
- 86.61M
- Total cash
- 111.54M
- Total debt
- 32.72M
- Return on equity
- -17.72%
- Shares outstanding
- 58.56M
- Short % of float
- 5.36%
- 50-day average
- 70.53
- 200-day average
- 53.51
Analyst view
Consensus: hold
- Target (low)
- 68.20
- Target (mean)
- 78.03
- Target (high)
- 80.00
- Strong buy1
- Buy0
- Hold6
- Sell0
- Strong sell0
Next earnings
Feb 28, 2024
Expected Feb 28, 2024. Consensus EPS estimate 0.00667.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 28, 2024 | Dec 1, 2023 | 0.01 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 8, 2025 | BTIG | down | Buy | Neutral |
| Jan 7, 2025 | Wells Fargo | down | Overweight | Equal-Weight |
| Jan 7, 2025 | William Blair | down | Outperform | Market Perform |
| Jan 7, 2025 | Piper Sandler | main | Neutral | Neutral |
| Jan 7, 2025 | Canaccord Genuity | down | Buy | Hold |
| Jan 7, 2025 | Baird | down | Outperform | Neutral |
About Inari Medical, Inc.
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. As of February 19, 2025, Inari Medical, Inc. operates as a subsidiary of Stryker Corporation.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- inarimedical.com
News
- If You Could Only Hold 3 Investments for Life, Consider These
- Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment
- Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation
- Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Shareholders to Connect
- Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Shareholders to Reach Out
- Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Shareholders to Learn More About the Investigation
- Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation
- Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Investors to Learn More About the Investigation
- Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
- Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Investors to Connect
Your note
Sign in to keep a note on NARI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHAMBERS REBECCA | Director | Sale | Jun 20, 2024 | 9,684 |
| HILL MITCH C | Chief Financial Officer | Sale | Sep 11, 2024 | 181,200 |
| HOFFMAN WILLIAM H | Director | Sale | Jan 5, 2025 | 238,987 |
| HYKES ANDREW J | Chief Executive Officer | Stock Award(Grant) | Feb 18, 2025 | 0 |
| LUCCHESE CYNTHIA L | Director | Stock Award(Grant) | Apr 23, 2024 | 38,429 |
| ROOT JONATHAN D | Director | Stock Award(Grant) | Apr 23, 2024 | 541,484 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 14.33% | 8,389,788 | 670.93M | Dec 30, 2024 |
| Vanguard Group Inc | 9.61% | 5,628,875 | 450.14M | Dec 30, 2024 |
| Hcc Manager LLC | 4.98% | 2,914,246 | 233.05M | Dec 30, 2024 |
| Morgan Stanley | 3.67% | 2,150,771 | 172.00M | Dec 30, 2024 |
| State Street Corporation | 3.56% | 2,083,195 | 166.59M | Dec 30, 2024 |
| Brown Advisory Inc. | 3.09% | 1,811,136 | 144.84M | Dec 30, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 5.54% | 3,243,299 | 259.37M | Nov 29, 2024 |
| Vanguard Total Stock Market Index Fund | 2.67% | 1,560,449 | 124.79M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.54% | 1,486,744 | 118.89M | Nov 29, 2024 |
| Vanguard Small-Cap Index Fund | 2.12% | 1,241,527 | 99.28M | Sep 29, 2024 |
| American Century Small Cap Growth Fund | 1.43% | 834,356 | 66.72M | Dec 30, 2024 |
| Baron Discovery Fund | 1.31% | 766,956 | 61.33M | Sep 29, 2024 |